ZYME
Zymeworks Inc.
Company Overview
| Mkt Cap | $1.27B | Price | $19.09 |
| Volume | 345.08K | Change | -0.18% |
| P/E Ratio | -10.4 | Open | $19.05 |
| Revenue | $76.3M | Prev Close | $19.12 |
| Net Income | $-122.7M | 52W Range | $9.03 - $19.98 |
| Div Yield | N/A | Target | $24.65 |
| Overall | 56 | Value | 60 |
| Quality | 44 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyZymeworks Inc. (ZYME) is a leading Healthcare company in the Biotechnology industry, currently trading at $19.09 with a market capitalization of $1.27 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows ZYME with a volume of 345K shares. The stock opened down 0.37% from yesterday's close of $19.12. Current analyst estimates project earnings of $-0.82 per share for this year, with next year targeting $-0.94.
ZYME demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ZYME include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 29.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:04 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZYME | $19.09 | -0.2% | 345.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |